SGCB and Hepatic fibrosis: In light of the findings of previous studies indicating that sGC agonists can mitigate renal and hepatic fibrosis to varying degrees [15], we conducted an investigation to ascertain whether vericiguat treatment could similarly reduce fibrosis indicators.